Clinical trials for Cancer in United States

NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making

Study ID: NCT05923684

Sponsor

Cedars-Sinai Medical Center

IVIG for Infection Prevention After CAR-T-Cell Therapy

Study ID: NCT05952804

Sponsor

Fred Hutchinson Cancer Center

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Study ID: NCT06079671

Sponsor

AstraZeneca

A Study of 177Lu-PSMA-617 in People With Gliomas

Study ID: NCT07223034

Sponsor

Memorial Sloan Kettering Cancer Center

The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts

Study ID: NCT05667532

Sponsor

M.D. Anderson Cancer Center

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Study ID: NCT06630221

Sponsor

Abhay Singh, MD MPH

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Study ID: NCT06567704

Sponsor

Wake Forest University Health Sciences

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Study ID: NCT06357533

Sponsor

AstraZeneca

Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers

Study ID: NCT05121051

Sponsor

National Cancer Institute (NCI)

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

Study ID: NCT06549465

Sponsor

Convergent Therapeutics